Posttraumatic Stress Disorder Clinical Trial
— CCTPTSDOfficial title:
Assessment and Treatment of Cognitive Functioning Deficits in Veterans With PTSD
Approximately half a million Veterans receiving services at the VA have Posttraumatic Stress Disorder (PTSD). PTSD is strongly associated with cognitive functioning deficits in areas of concentration, attention, memory, learning, verbal abilities, processing speed, and multitasking. Compensatory Cognitive Training (CCT) is an evidence-based intervention for cognitive problems that is effective in other Veteran populations such as those with a history of traumatic brain injury (TBI), but CCT has not yet been tested in Veterans with PTSD who don't have a history of TBI. The investigators will conduct a pilot randomized controlled trial (RCT) of CCT in Veterans who have been treated for PTSD but continue to have cognitive functioning deficits. The investigators will examine feasibility, acceptability, participant characteristics, and effect size estimates in preparation for a fully-powered RCT of CCT for PTSD-related cognitive functioning deficits.
Status | Recruiting |
Enrollment | 36 |
Est. completion date | December 29, 2024 |
Est. primary completion date | September 29, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Eligible Veterans must meet DSM-5 criteria for PTSD with evidence-based PTSD treatment participation within the past 2 years. - Must have an individual mental health provider/case manager assigned for coordination of care and management of crises as well as provision of treatment as usual if Veteran is randomly assigned to this condition. - Report subjective cognitive complaints, such as problems with memory, attention/concentration, and executive function (e.g., planning, organization, problem-solving, decision-making). - Referring provider observes mild cognitive problems that interfere with daily life (e.g., forgetting appointments or medications, poor performance at work or school, difficulty remembering information, trouble focusing in treatment sessions, trouble following through on goals). - Fluent English speaker. - Able to read and write and provide informed consent. Exclusion Criteria: - No history of traumatic brain injury (of any severity) or another major medical condition likely to significantly impact cognitive functioning such as stroke, MS, Parkinson's, or a brain tumor. - Do not meet criteria for bipolar disorder or a psychotic disorder. Do not have a diagnosis of a substance dependence disorder within the past 30 days. - Do not have active suicidal intent indicating significant clinical risk (which would suggest that a treatment targeting suicidal intent is indicated). - Cognitive problems are not severe (i.e., no dementia). Cognitive problems do NOT interfere with a Veteran's overall ability to live independently or care for him/herself. - Not currently participating in any type of brain stimulation treatment. - No significant auditory/visual impairments. |
Country | Name | City | State |
---|---|---|---|
United States | VA Portland Health Care System, Portland, OR | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prospective-Retrospective Memory Questionnaire (PRMQ; Crawford et al., 2006) | Cognitive symptoms. Higher scores represent worse outcomes. Total score ranges from 0-64. | change from baseline to 3 and 6 months | |
Primary | Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ; Benedict et al., 2003) | Cognitive symptoms. Higher scores represent worse outcomes. Total score ranges from 0-60. | change from baseline to 3 and 6 months | |
Primary | California Verbal Learning Test (CVLT-II; Delis et al., 2000) | verbal learning and memory; forced choice validity. Total score ranges from 0-80. Higher scores represent better outcomes. | change from baseline to 3 and 6 months | |
Primary | Wechsler Adult Intelligence Scale (WAIS-IV) Digit Span & Coding subtests (Wechsler, 2008) | attention, working memory, processing speed, reliable digit span validity. Higher scores represent better outcomes. Scores on each subtest range from 0-18 and are reported as WAIS Scaled Scores. | change from baseline to 3 and 6 months | |
Primary | Controlled Oral Word Association Test (Benton, Hamsher, & Sivan, 1983) | word generation, verbal fluency, executive functioning. Higher scores represent better outcomes. Total score ranges from 0-infinite, but are reported as t-scores with a range of 0-100. | change from baseline to 3 and 6 months | |
Primary | Halstead Reitan Trailmaking Test (Trails A & B; Reitan & Wolfson, 1985) | visual tracking, processing speed, executive functioning. Higher scores are the amount of time to complete the task and represent worse outcomes. Total scores are in seconds, but are converted to t-scores ranging from 0-100 with higher scores representing better outcomes once converted to t-scores. | change from baseline to 3 and 6 months | |
Primary | World Health Organization Disability Assessment Scale (WHODAS 2.0) | quality of life, global functioning. Higher scores represent worse outcomes. Total score ranges from 0-48. | change from baseline to 3 and 6 months | |
Primary | Neuro-QOL Cognitive, ability to participate in social roles and activities, and sleep scales | quality of life, cognitive functioning, sleep functioning, social functioning. Higher scores represent better outcomes. Scores on each subtest range from 8-40. | change from baseline to 3 and 6 months | |
Primary | Memory Compensation Questionnaire (MCQ; de Frias & Dixon, 2005) | compensatory cognitive strategy use. Higher scores represent better outcomes. Total score ranges from 0-176. | change from baseline to 3 and 6 months | |
Primary | Portland Cognitive Strategies Scale 2.0 (PCSS) | compensatory cognitive strategy use. Higher scores represent worse outcomes. Total score ranges from 0-60. | change from baseline to 3 and 6 months | |
Secondary | Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 2006) | mental health diagnoses. Scores are indicative of presence or absence of a diagnosis (categorical variable, therefore no range of scores is applicable). | change from baseline to 3 and 6 months | |
Secondary | PTSD Checklist (PCL-5; Weathers et al., 2013) | PTSD symptoms and severity. Higher scores represent worse outcomes. Total score ranges from 0-80. | change from baseline to 3 and 6 months | |
Secondary | Patient Health Questionnaire (PHQ-9; Spitzer, Kroenke, & Williams, 1999) | depression symptoms and severity. Higher scores represent worse outcomes. Total score ranges from 0-27. | change from baseline to 3 and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03384706 -
A Comparison of CPT Versus ART Versus WL
|
N/A | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03129204 -
Sensation Awareness Focused Training for Spouses
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT05113277 -
Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Recruiting |
NCT05843695 -
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Completed |
NCT00644423 -
Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT02989987 -
NET for SGBV Survivors in Eastern DR Congo
|
N/A | |
Completed |
NCT02320799 -
Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya
|
N/A | |
Recruiting |
NCT02293291 -
Thermal Clinic Treatment in Gulf War Illness
|
Phase 1/Phase 2 | |
Completed |
NCT02242136 -
Treatment of Posttraumatic Stress Disorder and Aggressive Behavior in Soldiers and Ex-combatants
|
N/A | |
Completed |
NCT01911585 -
Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure
|
N/A | |
Completed |
NCT02720497 -
The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT01693978 -
Contingency Outcomes in Prolonged Exposure
|
N/A | |
Completed |
NCT01469754 -
Longitudinal Survey Analysis in Lymphoma Survivors
|
N/A | |
Terminated |
NCT01239173 -
Emotional Memory Reactivation in Posttraumatic Stress Disorder
|
Phase 3 | |
Completed |
NCT02362477 -
Telemental Health and Cognitive Processing Therapy for Female Veterans With Military-related PTSD
|
Phase 3 |